Impact of COVID-19 pandemic on outpatient visit volume in cancer patients: Results of COMETA multicenter retrospective observational study.

COVID-19 cancer care facilities clinic activity healthcare research oncology service outpatients

Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2023
Historique:
received: 22 10 2022
accepted: 26 01 2023
entrez: 3 3 2023
pubmed: 4 3 2023
medline: 7 3 2023
Statut: epublish

Résumé

To evaluate the impact of the COVID-19 pandemic on first and follow-up visits for cancer outpatients. This is a multicenter retrospective observational study involving three Comprehensive Cancer Care Centers (CCCCs): IFO, including IRE and ISG in Rome, AUSL-IRCCS of Reggio Emilia, and IRCCS Giovanni Paolo II in Bari) and one oncology department in a Community Hospital (Saint'Andrea Hospital, Rome). From 1 January 2020 and 31 December 2021, we evaluated the volume of outpatient consultations (first visits and follow-up), comparing them with the pre-pandemic year (2019). Results were analyzed by quarter according to the Rt (real-time indicator used to assess the evolution of the pandemic). IFO and IRCCS Giovanni Paolo II were "COVID-free" while AUSL-IRCCS RE was a "COVID-mixed" Institute. Depending on the Rt, Sain't Andrea Hospital experienced a "swinging" organizational pathway (COVID-free/ COVID-mixed). Regarding the "first appointments", in 2020 the healthcare facilities operating in the North and Center of Italy showed a downward trend. In 2021, only AUSL-IRCCS RE showed an upward trend. Regarding the "follow-up", only AUSL IRCCS RE showed a slight up-trend in 2020. In 2021, IFO showed an increasing trend, while S. Andrea Hospital showed a negative plateau. Surprisingly, IRCCS Giovanni Paolo II in Bari showed an uptrend for both first appointment and follow-ups during pandemic and late pandemic except for the fourth quarter of 2021. During the first pandemic wave, no significant difference was observed amongst COVID-free and COVID-mixed Institutes and between CCCCs and a Community Hospital. In 2021 ("late pandemic year"), it has been more convenient to organize COVID-mixed pathway in the CCCCs rather than to keep the Institutions COVID-free. A swinging modality in the Community Hospital did not offer positive results in term of visit volumes. Our study about the impact of COVID-19 pandemic on visit volume in cancer outpatients may help health systems to optimize the post-pandemic use of resources and improve healthcare policies.

Identifiants

pubmed: 36866103
doi: 10.3389/fpubh.2023.1077103
pmc: PMC9971950
doi:

Types de publication

Observational Study Multicenter Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1077103

Informations de copyright

Copyright © 2023 Frisardi, Brunetti, Abbinante, Ardigò, Caolo, Di Turi, Torsello, Napoli, Mancini, Belleudi, Addis, Di Bella, Ciliberto, Neri, Corsini, Ruggieri, Pollorsi and Silvestris.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Semin Oncol. 2022 Apr;49(2):182-188
pubmed: 35606169
Cancer Med. 2021 Sep;10(18):6327-6335
pubmed: 34355873
Front Oncol. 2022 Jun 02;12:828660
pubmed: 35756683
Cancer Control. 2021 Jan-Dec;28:10732748211045275
pubmed: 34623943
BMC Cancer. 2020 Jul 10;20(1):641
pubmed: 32650756
Risk Manag Healthc Policy. 2020 Nov 16;13:2621-2626
pubmed: 33235532
MedGenMed. 2007 Nov 13;9(4):33
pubmed: 18311383
Ann Oncol. 2022 Jun;33(6):661-663
pubmed: 35276335
Nat Med. 2020 Jul;26(7):1146
pubmed: 32494062
JCO Clin Cancer Inform. 2020 Nov;4:1059-1071
pubmed: 33253013
BMC Public Health. 2021 Nov 11;21(1):2069
pubmed: 34763690
Environ Res. 2021 Apr;195:110874
pubmed: 33610582
Intern Med J. 2021 May;51(5):673-681
pubmed: 34047023
Int J Health Serv. 2007;37(1):193-8
pubmed: 17436992
Glob Health Res Policy. 2020 May 6;5:19
pubmed: 32391438
Int J Cancer. 2022 Jul 1;151(1):77-82
pubmed: 35128650
Lancet. 2022 Oct 8;400(10359):1224-1280
pubmed: 36115368
ESMO Open. 2021 Jun;6(3):100157
pubmed: 34015642
Tumori. 2015;101 Suppl 1:S42-6
pubmed: 27096272
Oncologist. 2021 Feb;26(2):e338-e341
pubmed: 33111460
Lancet Reg Health Eur. 2021 Jun 27;6:100151
pubmed: 34557834
Lancet Reg Health West Pac. 2021 May;10:100127
pubmed: 33778794
Cancers (Basel). 2020 Oct 12;12(10):
pubmed: 33053782
J Surg Oncol. 2020 Sep;122(3):371-372
pubmed: 32452031
Einstein (Sao Paulo). 2020 Dec 21;19:eAO6282
pubmed: 33338192
Epidemics. 2021 Dec;37:100528
pubmed: 34814093
PLoS Med. 2007 Oct 16;4(10):e297
pubmed: 17941715
Tumori. 2020 May 04;:300891620923790
pubmed: 32364028

Auteurs

Vincenza Frisardi (V)

Department of Neuromotor Diseases, Geriatric Unit, AUSL IRCCS of Reggio Emilia, Reggio Emilia, Italy.

Oronzo Brunetti (O)

Istituto Tumori "Giovanni Paolo II" of Bari, IRCCS, Bari, Italy.

Vincenza Abbinante (V)

Istituto Tumori "Giovanni Paolo II" of Bari, IRCCS, Bari, Italy.

Marco Ardigò (M)

San Gallicano Dermatological Institute IRCCS, Rome, Italy.

Giuseppina Caolo (G)

National Cancer Institute Regina Elena, Rome, Italy.

Annunziata Di Turi (A)

National Cancer Institute Regina Elena, Rome, Italy.

Alessandra Torsello (A)

Sapienza University of Rome, Saint'Andrea Hospital, Rome, Lazio, Italy.

Christian Napoli (C)

Sapienza University of Rome, Saint'Andrea Hospital, Rome, Lazio, Italy.

Rita Mancini (R)

Sapienza University of Rome, Saint'Andrea Hospital, Rome, Lazio, Italy.

Valeria Belleudi (V)

Department of Epidemiology, Lazio Regional Health Service, Rome, Italy.

Antonio Addis (A)

Department of Epidemiology, Lazio Regional Health Service, Rome, Italy.

Ornella Di Bella (O)

National Cancer Institute Regina Elena, Rome, Italy.

Gennaro Ciliberto (G)

National Cancer Institute Regina Elena, Rome, Italy.

Antonino Neri (A)

Scientific Directorate, AUSL-IRCCS of Reggio Emilia, Reggio Emilia, Italy.

Romina Corsini (R)

Scientific Directorate, AUSL-IRCCS of Reggio Emilia, Reggio Emilia, Italy.

Patrizia Ruggieri (P)

Scientific Directorate, AUSL-IRCCS of Reggio Emilia, Reggio Emilia, Italy.

Chiara Pollorsi (C)

Department of Neuromotor Diseases, Geriatric Unit, AUSL IRCCS of Reggio Emilia, Reggio Emilia, Italy.

Nicola Silvestris (N)

Medical Oncology Unit, Department of Human Pathology "G. Barresi", University of Messina, Messina, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH